Research location
Rijswijk
Netherlands
Advertisement
Research activity in Rijswijk
NetherlandsCureCurrent currently publishes aggregate city-level research activity for this location: 19 trials and 19 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Rijswijk
19 linked trials · page 1 of 1Observational Study on Non-steroid Anti-inflammatory Drugs (NSAIDs) Treated Patients With Arthritic DisorderNCT01176682 · 2010-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic ControlNCT00621140 · 2008-02-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential HypertensionNCT00760214 · 2008-01-01 · 1 site observation
COMPLETED
52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension PeriodNCT00575588 · 2007-12-01 · 1 site observation
COMPLETED
A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical PracticeNCT00505388 · 2007-07-01 · 1 site observation
COMPLETED
Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary PreventionNCT00689377 · 2007-05-01 · 1 site observation
COMPLETED
Local Phase 4 Pan-European SMART StudyNCT00463866 · 2007-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesNCT00348712 · 2006-10-30 · 1 site observation
TERMINATED
Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mgNCT00383929 · 2006-09-01 · 1 site observation
COMPLETED
Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive PatientsNCT00267943 · 2006-01-01 · 1 site observation
COMPLETED
Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5NCT00239369 · 2005-10-01 · 1 site observation
COMPLETED
G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)NCT00255645 · 2005-09-01 · 1 site observation
TERMINATED
GALLEX 1 - Long Term Extension Study in Patients With Type 2 DiabetesNCT00252876 · 2005-03-01 · 1 site observation
TERMINATED
GALLANT 5 Tesaglitazar Versus MetforminNCT00214591 · 2004-08-01 · 1 site observation
TERMINATED
PPAR-COMBO With SulfonylureaNCT00162175 · 2003-07-01 · 1 site observation
COMPLETED
A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)NCT00240474 · 2002-12-01 · 1 site observation
COMPLETED
A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular HypertensionNCT00150267 · 2002-02-01 · 1 site observation
COMPLETED
RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in DiabetesNCT00379769 · 2001-04-01 · 1 site observation
COMPLETED
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/GlibenclamideNCT00279045 · 2000-01-03 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.